|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 23, 2023 |
Title |
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To investigate in situ-in vitro molecular correspondence and the relationship between in vitro and patient response to temozolomide (TMZ)
|
|
|
Overall design |
Gene expression profiling analysis using data obtained from RNA-seq of 24 different GBM cell cultures
|
|
|
Contributor(s) |
Ntafoulis I, Kleijn A, Ju J, Jimenez-Cowell K, Fabro F, Klein M, Chi Yen RT, Balvers RK, Li Y, Stubbs AP, Kers TV, Kremer A, Byrne AT, O’Farrell AC, Lambrechts D, Dilcan G, Lodi F, Arijs I, Dirven CM, Leenstra S, Lamfers ML |
Citation(s) |
37620410, 37958662 |
Submission date |
May 10, 2023 |
Last update date |
Dec 07, 2023 |
Contact name |
Martine Lamfers |
Organization name |
Erasmus MC
|
Department |
Neurosurgery
|
Street address |
Wytemaweg 80
|
City |
Rotterdam |
State/province |
Zuid Holland |
ZIP/Postal code |
3015CN |
Country |
Netherlands |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (24)
|
|
Relations |
BioProject |
PRJNA971167 |
Supplementary file |
Size |
Download |
File type/resource |
GSE232173_count_data_24_cells.txt.gz |
838.2 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|